A hopeful therapy for Niemann-Pick C diseases - The Lancet
Por um escritor misterioso
Descrição
Decreased neural stem cell proliferation and olfaction in mouse
2023: The year in cardiovascular disease – the year of new and
Polyrotaxane-based systemic delivery of β-cyclodextrins for
A first therapy for Niemann-Pick C - The Lancet Neurology
Intrathecal 2-hydroxypropyl-β-cyclodextrin decreases neurological
Niemann–Pick Disease Type C1
Cost-effectiveness of miglustat versus symptomatic therapy of
Biomarker analysis of Niemann-Pick disease type C using
Central nervous system therapy for lysosomal storage disorders in
Advances in therapies for neurological lysosomal storage disorders
de
por adulto (o preço varia de acordo com o tamanho do grupo)
